Form 4: ATAI Life Sciences Chief Scientific Officer Sells Shares to Cover Tax Obligations

Glenn Frank Short, Chief Scientific Officer of ATAI Life Sciences N.V., sold 13,161 common shares on March 21, 2025, at a price of $1.35 to cover tax liabilities related to vesting restricted stock units.

Summary

• On March 21, 2025, Glenn Frank Short, the Chief Scientific Officer of ATAI Life Sciences N.V., sold 13,161 common shares.
• The shares were sold at a price of $1.35 per share.
• The sale was executed to satisfy the reporting person's tax liability on the vesting of restricted stock units.
• Following the transaction, Short directly owns 42,333 common shares.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) by a company officer, which is neither particularly positive nor negative.

Industry Context

Sales of shares by company officers are a normal part of corporate governance. It is important to consider the context of the sale, such as the reason for the sale and the amount of shares sold, in order to assess the potential impact on the company's stock price.

Stakeholder Impact

• The sale of shares by a company officer could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or financial performance.

Key Dates

Keywords

ATAI Life Sciences, Glenn Frank Short, Chief Scientific Officer, Form 4, Share Sale, Tax Liability, Restricted Stock Units, Insider Trading